|
Cancer site (ICD-10 )
|
Republic of Korea
|
Japan [7]
|
China [8]
|
France [5]
|
United Kingdom [6]
|
|---|
|
Men
|
Women
|
Men
|
Women
|
Men
|
Women
|
Men
|
Women
|
Men
|
Women
|
|---|
|
RR
|
PAF
|
RR
|
PAF
|
RR
|
PAF
|
RR
|
PAF
|
RR
|
PAF
|
RR
|
PAF
|
RR
|
PAF
|
RR
|
PAF
|
RR
|
PAF
|
RR
|
PAF
|
|---|
|
Oral Cavity (C00-C09)
|
3.3
|
62.0
|
3.3
|
8.2
|
2.4
|
50.0
|
1.8
|
8.5
|
1.5b
|
24.6
|
1.5a
|
2.8
|
4.2
|
63.1
|
1.6
|
17.0
|
10.9
|
70
|
5.1
|
55
|
|
Pharynx (C10-C14)
|
6.8
|
76.0
|
3.3
|
44.1
|
|
Esophagus (C15)
|
2.6
|
54.8
|
0.9
|
0.2
|
3.0
|
58.9
|
2.4
|
14.7
|
1.3c
|
17.9
|
1.3a
|
1.9
|
2.5
|
51.1
|
2.3
|
34.4
|
6.8
|
63
|
7.8
|
71
|
|
Stomach (C16)
|
1.6
|
31.6
|
1.0
|
0.2
|
1.4
|
23.5
|
1.3
|
3.4
|
1.7c
|
30.9
|
1.7a
|
3.8
|
1.7
|
31.1
|
1.5
|
14.3
|
2.2
|
26
|
1.5
|
15
|
|
Colorectum (C18-C20)
|
1.1
|
1.2
|
1.1
|
0.4
|
1.4
|
20.4
|
1.4
|
4.5
| | | | | | | | |
1.24
|
7
|
1.3
|
10
|
|
Liver (C22)
|
1.4
|
23.5
|
2.6
|
6.1
|
1.7
|
35.1
|
1.6
|
6.8
|
1.4b
|
18.7
|
1.2b
|
1.0
|
1.9
|
37.5
|
1.5
|
17.1
|
2.3
|
27
|
1.5
|
15
|
|
Pancreas (C25)
|
1.5
|
26.8
|
1.1
|
0.4
|
1.4
|
23.9
|
1.9
|
9.5
|
1.9c
|
35.5
|
1.9a
|
4.6
|
1.6
|
24.9
|
1.6d
|
17.0
|
2.2
|
26
|
2.2
|
31
|
|
Larynx (C32)
|
4.5
|
71.9
|
3.6
|
9.2
|
4.5
|
71.9
|
4.5
|
30.1
|
1.5b
|
24.6
|
1.5a
|
2.8
|
5.2
|
75.9
|
5.2d
|
64.8
|
14.6
|
79
|
13
|
79
|
|
Lung (C33-C34)
|
4.4
|
71.5
|
3.2
|
8.1
|
3.6
|
67.5
|
3.6
|
23.9
|
5.7c
|
75.0
|
5.0c
|
18.4
|
9.9
|
83.0
|
7.6
|
69.2
|
21.3
|
87
|
12.5
|
84
|
|
Cervix (C53)
|
-
|
-
|
1.8
|
3.1
|
-
|
-
|
2.0
|
10.9
|
-
|
-
|
1.8e
|
4.5
|
-
|
-
|
1.8
|
22.9
|
-
|
-
|
1.5
|
7
|
|
Ovary (C56)
|
-
|
-
|
2.1
|
4.0
|
-
|
-
|
0.9
|
-
| | | | | | | | |
-
|
-
|
2.1
|
3
|
|
Kidney (C64)
|
1.1
|
6.6
|
1.1
|
2.3
|
1.5
|
27.9
|
0.9
|
-
| | | | |
1.6
|
26.4
|
1.4
|
11.5
|
2.5g
|
29g
|
1.5g
|
15g
|
|
Bladder (C67)
|
2.1
|
44.9
|
2.0
|
3.8
|
4.3f
|
70.7f
|
1.3f
|
3.6f
|
1.9b
|
36.8
|
1.7b
|
3.6
|
2.8
|
52.8
|
2.7
|
39.3
|
3
|
38
|
2.4
|
34
|
|
Myeloid leukemia (C92)
|
-
|
-
|
-
|
-
|
1.7
|
33.5
|
1.0
|
-
| | | | | | | | |
1.9
|
19
|
1.2
|
6
|
|
Prevalence (%)
|
70.8 (11.7)h
|
3.9 (0.3)h
|
53.1 (19.8)i
|
9.7 (2.6)i
|
64.0j
|
5.6j
|
48.2k
|
30.4k
|
22l
|
21l
|
|
% of all cancers
|
32.9
|
5.2
|
34.4
|
6.2
|
32.7
|
5.0
|
33.4
|
9.6
|
23.0
|
15.6
|
-
aReplaced by men’s RR.
-
bRR of cancer mortality associated with smoking. SE for RR (not 95% CI) is provided in Liu’s retrospective proportional mortality study (involving cancer of oral cavity, pharynx and larynx).
-
cRR of cancer incidence associated with smoking.
-
dWhen RRs for women were higher than for men or when no RR was estimable for women, the RR for men was used instead.
-
eRR not derived from Chinese studies.
-
fRenal pelvis, Ureter, Bladder (C65-68).
-
gKidney and renal pelvis.
-
hPrevalence data for 1989 derived from the Korea National Health Examination Survey, current smoker’s prevalence and parenthesis represent former smoker’s prevalence.
-
iPrevalence data for 1990 derived from the National Nutrition Survey, current smoker’s prevalence and parenthesis represent former smoker’s prevalence.
-
jPrevalence data for ever-smoking and involuntary smoking of 1990 was estimated by linear interpolation using the results of these two national surveys.
-
kPrevalence data for 1985 were estimated by linear interpolation using results of surveys conducted in 1983 and 1986 (current smoker).
-
lPrevalence data for 2008 derived from General Lifestyle Survey 2008/ONS 2010 (current smoker).
